Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06789731 · ClinicalTrials.gov registry record · NA

Mindfulness-Based Interventions Targeting First-Generation College Student Retention in Rural Environments

A NA study of Depression and Anxiety, sponsored by University of South Dakota.

Recruiting
Registry status
NA
Development phase
53
Enrollment target
1
Study location

NCT06789731: Recruiting NA study of Depression and Anxiety, sponsored by University of South Dakota.

NCT06789731 is a NA study of Depression and Anxiety that is actively recruiting participants, run by University of South Dakota. The registered enrollment target is 53 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT06789731, a NA study of Depression and Anxiety, is actively recruiting participants, sponsored by University of South Dakota.

RECRUITING
Registry status
NA
Development phase
53 participants
Enrollment target
1
Study location

Study Summary

The goal of this randomized control group is to learn about effective treatments for college students experiencing anxiety and/or depression. The main questions this clinical trial aims to answer are: 1) Can mindfulness-based treatments increase retention rates among first-generation college students? 1) Can mindfulness-based treatments decrease anxiety and/or depression among first-generation college students? Participants will be randomly assigned to one of two intervention groups: mindfulness meditation or psychoeducation. Researchers will compare outcomes from each group to explore treatment differences.

Primary Outcome

Change in participants' intention to persist in college will be assessed through an individual item rated in a numeric rating scale. Scores range from 0 to 5 with higher scores reflecting greater intent to remain in college.

Conditions Studied

Interventions

  • OTHER Psychoeducation
  • BEHAVIORAL Mindfulness Meditation

Study Locations (1)

South Dakota

  • University of South Dakota - Sioux Falls

Trial Details

FieldValue
Enrollment Target 53 participants
Start Date 2025-01-01
Est. Completion 2027-06
Phase NA
University of South Dakota

12 total trials

What NCT06789731 shows while recruiting

NCT06789731 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 53 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (93% lower).

The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Psychoeducation is the first listed.

NCT06789731 reports a single indexed study location in South Dakota.

Frequently Asked Questions

What is clinical trial NCT06789731 about?

NCT06789731 is a clinical study titled "Mindfulness-Based Interventions Targeting First-Generation College Student Retention in Rural Environments". The goal of this randomized control group is to learn about effective treatments for college students experiencing anxiety and/or depression. The main questions this clinical trial aims to answer are: 1) Can mindfulness-based treatments increase retention rates among first-generation college student...

What is the current status of trial NCT06789731?

This trial is currently recruiting. It is a NA study. The enrollment target is 53 participants. The study started on 2025-01-01. Estimated completion is 2027-06.

What conditions does trial NCT06789731 study?

This clinical trial studies the following conditions: Depression, Anxiety.

What interventions are being tested in trial NCT06789731?

The interventions under investigation include: Psychoeducation (OTHER), Mindfulness Meditation (BEHAVIORAL).

Who is sponsoring clinical trial NCT06789731?

This trial is sponsored by University of South Dakota, which has 12 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06789731 being conducted?

This trial has 1 study location across South Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06789731's enrollment target sits among peer trials

53 462nd of 679 higher than 216 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04177004 · 53 participants · Phase 1

    Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant

  • NCT04199741 · 53 participants · Phase 1

    PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56

  • NCT04835129 · 53 participants · Phase 2

    Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma

  • NCT04913805 · 53 participants · Phase 2

    Matching Perfusion and Metabolic Activity in HFpEF

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT06789731, the US trial registry maintained by the National Library of Medicine. NCT06789731 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.